Prevalence of Novel Lamivudine-Resistant Genotypes (E44D/A, V118I) in Naive and Pretreated HIV-Infected Individuals
- 1 September 2000
- journal article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 25 (1) , 95-96
- https://doi.org/10.1097/00042560-200009010-00015
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- A Novel Human Immunodeficiency Virus Type 1 Reverse Transcriptase Mutational Pattern Confers Phenotypic Lamivudine Resistance in the Absence of Mutation 184VAntimicrobial Agents and Chemotherapy, 2000
- Multiple drug resistance genotype causing failure of antiretroviral treatment in an HIV-infected patient heavily exposed to nucleoside analogues.European Journal of Clinical Microbiology & Infectious Diseases, 1999
- High prevalence of multiple drug resistance mutations in a UK HIV/AIDS patient populationAIDS, 1999
- A 6-basepair insert in the reverse transcriptase gene of human immunodeficiency virus type 1 confers resistance to multiple nucleoside inhibitors.Journal of Clinical Investigation, 1998
- Multiple dideoxynucleoside analogue-resistant (MddNR) HIV-1 strains isolated from patients from different European countriesAIDS, 1998
- The M184 V mutation in HIV-1 reverse transcriptase (RT) conferring lamivudine resistance does not result in broad cross-resistance to nucleoside analogue RT inhibitorsAIDS, 1998
- Development of HIV-1 resistance to (−)2′-deoxy-3′-thiacytidine in patients with AIDS or advanced AIDS-related complexAIDS, 1995